Non-Hodgkin lymphoma: Symptoms, diagnosis, and treatment

Non-Hodgkin lymphoma, often shortened to NHL, is one of those medical terms that sounds like it should come with a dramatic movie soundtrack. In real life, it is not a single disease but a large family of cancers that begin in lymphocytes, the white blood cells that help the immune system fight infections. Because lymphocytes travel through lymph nodes, the spleen, bone marrow, blood, and other tissues, non-Hodgkin lymphoma can appear in many different places in the body. That is why one person may notice a painless lump in the neck, while another may feel unusually tired, sweaty at night, or full after eating two bites of dinner.

The good news is that doctors now understand non-Hodgkin lymphoma much better than they did decades ago. Today, diagnosis is more precise, treatment is more personalized, and many people live for years after treatment, especially when the lymphoma is found and managed appropriately. The slightly annoying news is that NHL can be sneaky. Its symptoms may look like a stubborn cold, stress, aging, or “I probably just need more sleep.” Your body, however, is not a spam folder. When it keeps sending the same message, it deserves attention.

What is non-Hodgkin lymphoma?

Non-Hodgkin lymphoma is cancer that starts in lymphocytes. These cells are part of the lymphatic system, a network that includes lymph nodes, lymph vessels, the spleen, thymus, tonsils, and bone marrow. The lymphatic system works like the body’s security team: it filters fluid, traps germs, and helps coordinate immune responses. In NHL, some lymphocytes grow and multiply in an abnormal way. Instead of doing their job and retiring politely, they keep dividing and can collect in lymph nodes or other organs.

There are many types of non-Hodgkin lymphoma. Most begin in B cells, while others begin in T cells or natural killer cells. Some types are indolent, meaning slow-growing. Others are aggressive, meaning they grow quickly and need treatment sooner. A slow-growing lymphoma is not automatically harmless, and an aggressive lymphoma is not automatically hopeless. The exact type matters because treatment for follicular lymphoma, diffuse large B-cell lymphoma, mantle cell lymphoma, marginal zone lymphoma, or T-cell lymphoma can differ significantly.

Common symptoms of non-Hodgkin lymphoma

The most common symptom of non-Hodgkin lymphoma is one or more swollen lymph nodes. These may feel like lumps under the skin, often in the neck, armpit, or groin. They are usually painless, which is one reason people may ignore them at first. A tender lymph node after a sore throat may simply mean your immune system is doing push-ups. But a lump that sticks around, grows, or appears with other symptoms should be checked.

Warning signs to watch for

Symptoms of non-Hodgkin lymphoma may include:

• Painless swelling in the neck, armpit, groin, or abdomen
• Unexplained fever
• Drenching night sweats
• Unexplained weight loss
• Persistent fatigue that does not improve with rest
• Itchy skin or rash
• Chest pain, coughing, or shortness of breath
• Abdominal pain, swelling, nausea, or feeling full quickly
• Frequent infections, easy bruising, or unusual bleeding

Doctors often pay close attention to what are called “B symptoms”: fever, drenching night sweats, and unexplained weight loss. These symptoms can happen with several lymphoma types and may influence staging and treatment decisions. “Drenching” is the key word. This is not “I used a heavy blanket in July.” It means waking up with clothes or sheets soaked enough that changing them sounds like a reasonable life choice at 3 a.m.

Why symptoms can be confusing

Non-Hodgkin lymphoma symptoms overlap with many common conditions, including viral infections, autoimmune problems, allergies, and ordinary fatigue. A swollen lymph node does not automatically mean cancer. Infections are far more common. Still, persistent symptoms deserve medical evaluation. A useful rule of thumb is this: if a lump, fever, weight loss, or fatigue is unexplained, worsening, or lasting several weeks, do not let internet reassurance become your primary care plan.

Symptoms may also depend on where lymphoma develops. Lymphoma in the chest can cause cough, pressure, or trouble breathing. Lymphoma in the abdomen may cause bloating, pain, constipation, appetite changes, or a feeling of fullness. Lymphoma affecting bone marrow may lead to low blood counts, which can cause fatigue, infections, bruising, or bleeding. Skin lymphomas may cause patches, plaques, itching, or rash-like changes.

Risk factors for non-Hodgkin lymphoma

Most people diagnosed with non-Hodgkin lymphoma did not do anything to “cause” it. Cancer is not a moral report card, and lymphoma is not a punishment for eating fries. However, certain factors can raise risk. NHL becomes more common with age and is somewhat more common in men. A weakened immune system, autoimmune diseases, certain infections, prior cancer treatment, family history, and exposure to some chemicals or radiation may also increase risk.

Infections linked to some lymphoma types include Epstein-Barr virus, HIV, human T-cell leukemia virus type 1, hepatitis C, and Helicobacter pylori in certain stomach lymphomas. Immune suppression after organ transplant or from medications can also increase risk. Some autoimmune diseases, such as rheumatoid arthritis, lupus, or celiac disease, have been associated with higher lymphoma risk. Risk factors are not guarantees, but they help doctors understand the bigger picture.

How non-Hodgkin lymphoma is diagnosed

Diagnosis usually begins with a medical history and physical exam. A clinician may check lymph nodes in the neck, underarms, and groin, and may examine the abdomen for an enlarged spleen or liver. They will ask about fever, night sweats, weight loss, infections, medications, immune conditions, and family history. From there, testing often moves from “What might this be?” to “Let’s identify the exact type.”

Biopsy: the key test

A biopsy is the most important test for diagnosing non-Hodgkin lymphoma. During a biopsy, a doctor removes part or all of an affected lymph node or another suspicious tissue sample. A pathologist then examines the cells under a microscope and uses specialized tests to identify the lymphoma type. Whenever possible, doctors often prefer an excisional biopsy, which removes an entire lymph node, because it gives the lab more tissue to study. Needle biopsies may be used in some cases, especially when the lymph node is hard to reach.

Blood tests and imaging

Blood tests cannot usually diagnose NHL by themselves, but they provide valuable clues. A complete blood count can show anemia, low white blood cells, or low platelets. Chemistry tests can evaluate kidney and liver function. Lactate dehydrogenase, often called LDH, may be measured because high levels can reflect more active disease in some cases. Doctors may also test for infections such as hepatitis B, hepatitis C, or HIV before certain treatments.

Imaging helps determine where lymphoma is located. CT scans, PET scans, MRI, ultrasound, or chest X-rays may be used depending on symptoms and suspected disease sites. PET/CT scans are especially useful for many aggressive lymphomas because they show areas of high metabolic activity. In some cases, a bone marrow biopsy may be done to see whether lymphoma has involved the marrow.

Understanding staging and grading

Staging describes how far lymphoma has spread. In general, stage I means lymphoma is limited to one lymph node area or one nearby site. Stage II means two or more lymph node areas are involved on the same side of the diaphragm. Stage III means lymph node areas on both sides of the diaphragm are involved. Stage IV means lymphoma is more widely spread, such as to bone marrow, liver, lungs, or other organs.

Staging helps guide treatment, but it does not tell the whole story. Unlike many solid tumors, some lymphomas can still be very treatable even at advanced stages. Doctors also consider lymphoma subtype, tumor size, symptoms, blood test results, age, overall health, and whether the disease is indolent or aggressive. In other words, stage matters, but it is not the entire biography.

Treatment options for non-Hodgkin lymphoma

Treatment for non-Hodgkin lymphoma depends on the exact subtype, stage, symptoms, growth rate, prior treatments, and the patient’s overall health. There is no one-size-fits-all plan. The best treatment is the one matched to the biology of the lymphoma and the needs of the person living with it.

Watchful waiting

Some slow-growing lymphomas do not need treatment immediately. This approach is called watchful waiting or active surveillance. It does not mean doctors are ignoring the cancer. It means the care team monitors the lymphoma with exams, blood tests, and imaging when needed, starting treatment only if symptoms develop or the disease changes. For some people, this can delay treatment side effects for months or years.

Chemotherapy

Chemotherapy uses drugs to kill fast-growing cells. It may be given alone or with immunotherapy. One common regimen for certain aggressive B-cell lymphomas is R-CHOP, which combines chemotherapy drugs with rituximab, an antibody that targets CD20 on B cells. Chemotherapy can be very effective, but it may cause fatigue, nausea, hair loss, infection risk, mouth sores, and low blood counts. Supportive medications have improved a lot, so treatment is often more manageable than people imagine, though still no one’s idea of a spa weekend.

Immunotherapy and monoclonal antibodies

Immunotherapy helps the immune system recognize or attack lymphoma cells. Monoclonal antibodies, such as rituximab and obinutuzumab, attach to proteins on lymphoma cells and help the immune system destroy them. These drugs are commonly used in B-cell lymphomas. Side effects may include infusion reactions, fever, chills, fatigue, or infection risk, especially when combined with chemotherapy.

Targeted therapy

Targeted therapies attack specific pathways that lymphoma cells use to grow or survive. Examples include BTK inhibitors, PI3K inhibitors, BCL-2 inhibitors, EZH2 inhibitors, and antibody-drug conjugates, depending on the lymphoma type and treatment history. These treatments can be useful for relapsed or refractory disease and, in some cases, earlier treatment. Because targeted drugs can have unique side effects, patients need careful monitoring.

Radiation therapy

Radiation therapy uses high-energy beams to treat lymphoma in a specific area. It may be used for early-stage disease, bulky lymph nodes, symptom control, or after chemotherapy in selected cases. Radiation is local treatment, meaning it focuses on one area rather than the whole body. Side effects depend on where radiation is aimed and may include skin changes, fatigue, dry mouth, swallowing discomfort, or organ-specific effects.

CAR T-cell therapy

CAR T-cell therapy is a newer form of immunotherapy used for certain relapsed or refractory B-cell lymphomas. Doctors collect a patient’s T cells, modify them in a lab so they can recognize cancer cells, and infuse them back into the body. It sounds futuristic because, frankly, it is. CAR T-cell therapy can lead to powerful responses, but it can also cause serious side effects such as cytokine release syndrome and neurologic problems, so it is given at specialized centers.

Stem cell transplant

Stem cell transplant may be considered for some people with lymphoma that returns or does not respond well to initial therapy. In an autologous transplant, a patient’s own stem cells are collected, high-dose chemotherapy is given, and the stem cells are returned to rebuild the bone marrow. An allogeneic transplant uses donor cells and is less common because it carries greater risks. Transplant decisions are highly individualized.

Side effects and supportive care

Treating non-Hodgkin lymphoma is not just about attacking cancer cells. It is also about protecting the person. Supportive care may include anti-nausea medicine, antibiotics, antiviral medication, growth factors, blood transfusions, nutrition support, vaccines when appropriate, fertility counseling, physical therapy, and mental health care. Good supportive care can help patients stay on treatment and recover more safely.

Patients should tell their care team about fever, chills, shortness of breath, uncontrolled vomiting, severe diarrhea, bleeding, confusion, new weakness, chest pain, or signs of infection. During treatment, even a fever can be more than “just a fever,” especially when white blood cell counts are low. When in doubt, call the oncology team. They would rather hear from you early than meet your symptoms after they have invited complications over for dinner.

Prognosis: what survival numbers do and do not mean

Survival statistics can be helpful, but they are broad averages. They do not predict exactly what will happen to one person. In the United States, the overall five-year relative survival rate for non-Hodgkin lymphoma is around the mid-70% range, but outcomes vary widely by subtype, stage, age, treatment response, and overall health. Some lymphomas are curable. Others may behave more like chronic illnesses, with periods of remission and relapse.

A person with early-stage indolent lymphoma has a very different outlook from someone with aggressive lymphoma that has returned after several therapies. At the same time, aggressive lymphomas can sometimes respond dramatically to treatment. This is why the most useful question is not simply “What is the survival rate?” but “What does my exact diagnosis mean, and what are my treatment goals?”

Questions to ask your doctor

After a diagnosis, it is normal for the brain to open 37 browser tabs at once. Bringing a written question list can help. Consider asking:

• What exact type of non-Hodgkin lymphoma do I have?
• Is it indolent or aggressive?
• What stage is it, and what tests determined that?
• Do I need treatment now, or is watchful waiting appropriate?
• What are the goals of treatment: cure, remission, control, or symptom relief?
• What side effects should I expect, and which ones are emergencies?
• Should I get a second opinion from a lymphoma specialist?
• Are clinical trials available for my type of lymphoma?

Living with non-Hodgkin lymphoma

Living with NHL can affect work, sleep, appetite, relationships, finances, and emotional health. Some people feel strong and focused. Others feel anxious, angry, numb, or overwhelmed. All of those reactions are human. Cancer has a talent for barging into life without checking the calendar first.

Practical support matters. Patients may need help with transportation, insurance paperwork, meals, childcare, appointment notes, or medication schedules. A trusted friend or family member can attend visits and take notes. Many cancer centers also offer social workers, financial counselors, dietitians, oncology nurses, patient navigators, and support groups. These resources are not “extras.” They are part of care.

Experience-based lessons: what the journey can feel like

For many people, the non-Hodgkin lymphoma experience begins with uncertainty. A lump appears in the neck or groin, but it does not hurt. At first, it is easy to blame a cold, a pulled muscle, or the mysterious category known as “probably nothing.” Then the lump stays. Maybe night sweats begin. Maybe fatigue arrives like an unwanted roommate who eats all the snacks and refuses to leave. This early stage can be frustrating because symptoms are real, but answers may take time.

One common experience is learning that diagnosis is a process, not a single appointment. A primary care visit may lead to blood tests. Blood tests may lead to imaging. Imaging may lead to a biopsy. The biopsy may need additional laboratory studies before the final subtype is clear. Waiting for results can be emotionally exhausting. Many patients describe this period as one of the hardest parts because they are living between “something is wrong” and “here is the plan.” During that time, it helps to write down symptoms, track fevers or weight changes, and keep a folder of test results. Organization does not cure anxiety, but it gives anxiety fewer loose papers to throw around.

Treatment experiences vary widely. A person on watchful waiting may feel strange knowing cancer is present but not being treated right away. That can feel counterintuitive, like seeing a small kitchen fire and being told, “Let’s monitor the smoke.” But for some indolent lymphomas, immediate treatment does not always improve outcomes and may only add side effects sooner. Good communication with the oncology team is essential so watchful waiting feels like active care rather than abandonment.

People receiving chemotherapy or immunotherapy often learn to plan life in cycles. There may be treatment days, tired days, cautious days, and “I actually feel pretty decent” days. Fatigue can be different from ordinary tiredness; it may feel like the body’s battery has been replaced with a potato. Patients often find it helpful to accept help before they are completely drained. Short walks, hydration, small protein-rich meals, and honest rest can make a difference, but every person’s tolerance is different.

Another experience is discovering that emotional recovery does not always match the treatment calendar. Friends may celebrate the end of therapy while the patient is still dealing with scans, follow-up visits, fear of recurrence, neuropathy, fatigue, or identity changes. Remission can bring relief and anxiety at the same time. Many survivors describe scan appointments as emotionally intense, sometimes called “scanxiety.” This is normal. Support groups, counseling, survivorship clinics, and open conversations with loved ones can help people process what happened and rebuild confidence.

Family members and caregivers also go through the journey. They may want to fix everything, but lymphoma does not respond to motivational speeches or casseroles alone, although casseroles are still welcome. The most useful support is often specific: driving to treatment, picking up prescriptions, sitting quietly during infusions, managing appointment calendars, or simply saying, “I’m here, and you don’t have to perform bravery for me.”

The biggest lesson from the non-Hodgkin lymphoma experience is that knowledge reduces fear, but compassion carries people through. Understanding the subtype, treatment plan, side effects, and follow-up schedule helps patients make informed decisions. At the same time, it is okay to have bad days. It is okay to ask questions twice. It is okay to laugh at awkward moments, cry in parking lots, and celebrate small victories like normal blood counts or a meal that finally tastes good again. NHL care is medical, but healing is also deeply human.

Conclusion

Non-Hodgkin lymphoma is a complex group of blood cancers, but complexity does not mean chaos. The most important steps are recognizing persistent symptoms, getting an accurate biopsy-based diagnosis, identifying the exact lymphoma subtype, and choosing treatment based on the biology of the disease and the patient’s needs. Symptoms such as painless swollen lymph nodes, fever, drenching night sweats, unexplained weight loss, fatigue, itching, chest pressure, or abdominal swelling should not be ignored, especially when they last or worsen.

Treatment may include watchful waiting, chemotherapy, immunotherapy, targeted therapy, radiation therapy, CAR T-cell therapy, stem cell transplant, or clinical trials. Many people respond well to modern treatment, and supportive care can make the journey safer and more manageable. If you or someone you love is facing non-Hodgkin lymphoma, the best next step is not panic-scrolling at midnight. It is building a knowledgeable care team, asking clear questions, and taking the process one decision at a time.